Global Dry Eye Syndrome Drugs Market 2024-2028

Publisher TechNavio

Published May 21, 2024

Length 168 Pages

SKU # INF18930191

Description

Global Dry Eye Syndrome Drugs Market 2024-2028

The dry eye syndrome drugs market is forecasted to grow by USD 2136.2 mn during 2023-2028, accelerating at a CAGR of 6.16% during the forecast period. The report on the dry eye syndrome drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing geriatric population, growing healthcare expenditure, and changing lifestyles and rising cases of diseases contributing to dry eye syndrome.

Technavio's dry eye syndrome drugs market is segmented as below:

By Distribution Channel

Retail pharmacies
Hospital pharmacies
Online pharmacies

By Product

OTC drugs
Prescription drugs

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advancements in drug delivery technologies as one of the prime reasons driving the dry eye syndrome drugs market growth during the next few years. Also, advancement in diagnostic techniques for dry eye syndrome and shift of dry eye syndrome drugs toward personalized medicine will lead to sizable demand in the market.

The report on the dry eye syndrome drugs market covers the following areas:

Dry eye syndrome drugs market sizing
Dry eye syndrome drugs market forecast
Dry eye syndrome drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading dry eye syndrome drugs market vendors that include Abbott Laboratories, AbbVie Inc., AFT Pharmaceuticals Ltd., Akorn Operating Co LLC, Bausch Health Companies Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, I MED Pharma Inc., Johnson and Johnson Services Inc., Laboratoires Thea, Mitotech SA, Novaliq GmbH, Novartis AG, Oasis Medical Inc., Otsuka Holdings Co. Ltd., Santen Pharmaceutical Co. Ltd., Sentiss Pharma Pvt. Ltd., Sun Pharmaceutical Industries Ltd., Viatris Inc., and Visufarma. Also, the dry eye syndrome drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market by Geography; Executive Summary - Chart on Market Segmentation by Distribution Channel; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Dry Eye Syndrome Drugs Market 2018 - 2022; Historic Market Size - Data Table on Global Dry Eye Syndrome Drugs Market 2018 - 2022 ($ million); 4.2 Distribution Channel segment analysis 2018 - 2022; Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million); 4.3 Product segment analysis 2018 - 2022; Historic Market Size - Product Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Distribution Channel: 6.1 Market segments; Chart on Distribution Channel - Market share 2023-2028 (%); Data Table on Distribution Channel - Market share 2023-2028 (%); 6.2 Comparison by Distribution Channel; Chart on Comparison by Distribution Channel; Data Table on Comparison by Distribution Channel; 6.3 Retail pharmacies - Market size and forecast 2023-2028; Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million); Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million); Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%); Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%); 6.4 Hospital pharmacies - Market size and forecast 2023-2028; Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million); Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million); Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%); Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%); 6.5 Online pharmacies - Market size and forecast 2023-2028; Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million); Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million); Chart on Online pharmacies - Year-over-year growth 2023-2028 (%); Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by Distribution Channel; Market opportunity by Distribution Channel ($ million); Data Table on Market opportunity by Distribution Channel ($ million)
7 Market Segmentation by Product: 7.1 Market segments; Chart on Product - Market share 2023-2028 (%); Data Table on Product - Market share 2023-2028 (%); 7.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 7.3 OTC drugs - Market size and forecast 2023-2028; Chart on OTC drugs - Market size and forecast 2023-2028 ($ million); Data Table on OTC drugs - Market size and forecast 2023-2028 ($ million); Chart on OTC drugs - Year-over-year growth 2023-2028 (%); Data Table on OTC drugs - Year-over-year growth 2023-2028 (%); 7.4 Prescription drugs - Market size and forecast 2023-2028; Chart on Prescription drugs - Market size and forecast 2023-2028 ($ million); Data Table on Prescription drugs - Market size and forecast 2023-2028 ($ million); Chart on Prescription drugs - Year-over-year growth 2023-2028 (%); Data Table on Prescription drugs - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by Product; Market opportunity by Product ($ million); Data Table on Market opportunity by Product ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape2023-2028 (%); Data Table on Market share By Geographical Landscape2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.9 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ million); Data Table on Japan - Market size and forecast 2023-2028 ($ million); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.10 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.11 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity by geography; Market opportunity By Geographical Landscape($ million); Data Tables on Market opportunity By Geographical Landscape($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Abbott Laboratories; Abbott Laboratories - Overview; Abbott Laboratories - Business segments; Abbott Laboratories - Key news; Abbott Laboratories - Key offerings; Abbott Laboratories - Segment focus; 12.4 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; 12.5 AFT Pharmaceuticals Ltd.; AFT Pharmaceuticals Ltd. - Overview; AFT Pharmaceuticals Ltd. - Business segments; AFT Pharmaceuticals Ltd. - Key offerings; AFT Pharmaceuticals Ltd. - Segment focus; 12.6 Bausch Health Companies Inc.; Bausch Health Companies Inc. - Overview; Bausch Health Companies Inc. - Business segments; Bausch Health Companies Inc. - Key news; Bausch Health Companies Inc. - Key offerings; Bausch Health Companies Inc. - Segment focus; 12.7 I MED Pharma Inc.; I MED Pharma Inc. - Overview; I MED Pharma Inc. - Product / Service; I MED Pharma Inc. - Key offerings; 12.8 Johnson and Johnson Services Inc.; Johnson and Johnson Services Inc. - Overview; Johnson and Johnson Services Inc. - Business segments; Johnson and Johnson Services Inc. - Key news; Johnson and Johnson Services Inc. - Key offerings; Johnson and Johnson Services Inc. - Segment focus; 12.9 Laboratoires Thea; Laboratoires Thea - Overview; Laboratoires Thea - Product / Service; Laboratoires Thea - Key offerings; 12.10 Mitotech SA; Mitotech SA - Overview; Mitotech SA - Product / Service; Mitotech SA - Key offerings; 12.11 Novaliq GmbH; Novaliq GmbH - Overview; Novaliq GmbH - Product / Service; Novaliq GmbH - Key offerings; 12.12 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; 12.13 Oasis Medical Inc.; Oasis Medical Inc. - Overview; Oasis Medical Inc. - Product / Service; Oasis Medical Inc. - Key offerings; 12.14 Otsuka Holdings Co. Ltd.; Otsuka Holdings Co. Ltd. - Overview; Otsuka Holdings Co. Ltd. - Business segments; Otsuka Holdings Co. Ltd. - Key offerings; Otsuka Holdings Co. Ltd. - Segment focus; 12.15 Santen Pharmaceutical Co. Ltd.; Santen Pharmaceutical Co. Ltd. - Overview; Santen Pharmaceutical Co. Ltd. - Product / Service; Santen Pharmaceutical Co. Ltd. - Key offerings; 12.16 Sun Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd. - Overview; Sun Pharmaceutical Industries Ltd. - Product / Service; Sun Pharmaceutical Industries Ltd. - Key news; Sun Pharmaceutical Industries Ltd. - Key offerings; 12.17 Viatris Inc.; Viatris Inc. - Overview; Viatris Inc. - Business segments; Viatris Inc. - Key news; Viatris Inc. - Key offerings; Viatris Inc. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market by Geography; Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits6: Executive Summary - Chart on Market Segmentation by Product; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Dry Eye Syndrome Drugs Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Product Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Distribution Channel - Market share 2023-2028 (%); Exhibits33: Data Table on Distribution Channel - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Distribution Channel; Exhibits35: Data Table on Comparison by Distribution Channel; Exhibits36: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%); Exhibits44: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million); Exhibits45: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million); Exhibits46: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%); Exhibits47: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%); Exhibits48: Market opportunity by Distribution Channel ($ million); Exhibits49: Data Table on Market opportunity by Distribution Channel ($ million); Exhibits50: Chart on Product - Market share 2023-2028 (%); Exhibits51: Data Table on Product - Market share 2023-2028 (%); Exhibits52: Chart on Comparison by Product; Exhibits53: Data Table on Comparison by Product; Exhibits54: Chart on OTC drugs - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on OTC drugs - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on OTC drugs - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on OTC drugs - Year-over-year growth 2023-2028 (%); Exhibits58: Chart on Prescription drugs - Market size and forecast 2023-2028 ($ million); Exhibits59: Data Table on Prescription drugs - Market size and forecast 2023-2028 ($ million); Exhibits60: Chart on Prescription drugs - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Prescription drugs - Year-over-year growth 2023-2028 (%); Exhibits62: Market opportunity by Product ($ million); Exhibits63: Data Table on Market opportunity by Product ($ million); Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits65: Chart on Market share By Geographical Landscape2023-2028 (%); Exhibits66: Data Table on Market share By Geographical Landscape2023-2028 (%); Exhibits67: Chart on Geographic comparison; Exhibits68: Data Table on Geographic comparison; Exhibits69: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits70: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits71: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits72: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits73: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits102: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits103: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits105: Market opportunity By Geographical Landscape($ million); Exhibits106: Data Tables on Market opportunity By Geographical Landscape($ million); Exhibits107: Impact of drivers and challenges in 2023 and 2028; Exhibits108: Overview on criticality of inputs and factors of differentiation; Exhibits109: Overview on factors of disruption; Exhibits110: Impact of key risks on business; Exhibits111: Companies covered; Exhibits112: Matrix on companies position and classification; Exhibits113: Abbott Laboratories - Overview; Exhibits114: Abbott Laboratories - Business segments; Exhibits115: Abbott Laboratories - Key news; Exhibits116: Abbott Laboratories - Key offerings; Exhibits117: Abbott Laboratories - Segment focus; Exhibits118: AbbVie Inc. - Overview; Exhibits119: AbbVie Inc. - Product / Service; Exhibits120: AbbVie Inc. - Key news; Exhibits121: AbbVie Inc. - Key offerings; Exhibits122: AFT Pharmaceuticals Ltd. - Overview; Exhibits123: AFT Pharmaceuticals Ltd. - Business segments; Exhibits124: AFT Pharmaceuticals Ltd. - Key offerings; Exhibits125: AFT Pharmaceuticals Ltd. - Segment focus; Exhibits126: Bausch Health Companies Inc. - Overview; Exhibits127: Bausch Health Companies Inc. - Business segments; Exhibits128: Bausch Health Companies Inc. - Key news; Exhibits129: Bausch Health Companies Inc. - Key offerings; Exhibits130: Bausch Health Companies Inc. - Segment focus; Exhibits131: I MED Pharma Inc. - Overview; Exhibits132: I MED Pharma Inc. - Product / Service; Exhibits133: I MED Pharma Inc. - Key offerings; Exhibits134: Johnson and Johnson Services Inc. - Overview; Exhibits135: Johnson and Johnson Services Inc. - Business segments; Exhibits136: Johnson and Johnson Services Inc. - Key news; Exhibits137: Johnson and Johnson Services Inc. - Key offerings; Exhibits138: Johnson and Johnson Services Inc. - Segment focus; Exhibits139: Laboratoires Thea - Overview; Exhibits140: Laboratoires Thea - Product / Service; Exhibits141: Laboratoires Thea - Key offerings; Exhibits142: Mitotech SA - Overview; Exhibits143: Mitotech SA - Product / Service; Exhibits144: Mitotech SA - Key offerings; Exhibits145: Novaliq GmbH - Overview; Exhibits146: Novaliq GmbH - Product / Service; Exhibits147: Novaliq GmbH - Key offerings; Exhibits148: Novartis AG - Overview; Exhibits149: Novartis AG - Business segments; Exhibits150: Novartis AG - Key news; Exhibits151: Novartis AG - Key offerings; Exhibits152: Novartis AG - Segment focus; Exhibits153: Oasis Medical Inc. - Overview; Exhibits154: Oasis Medical Inc. - Product / Service; Exhibits155: Oasis Medical Inc. - Key offerings; Exhibits156: Otsuka Holdings Co. Ltd. - Overview; Exhibits157: Otsuka Holdings Co. Ltd. - Business segments; Exhibits158: Otsuka Holdings Co. Ltd. - Key offerings; Exhibits159: Otsuka Holdings Co. Ltd. - Segment focus; Exhibits160: Santen Pharmaceutical Co. Ltd. - Overview; Exhibits161: Santen Pharmaceutical Co. Ltd. - Product / Service; Exhibits162: Santen Pharmaceutical Co. Ltd. - Key offerings; Exhibits163: Sun Pharmaceutical Industries Ltd. - Overview; Exhibits164: Sun Pharmaceutical Industries Ltd. - Product / Service; Exhibits165: Sun Pharmaceutical Industries Ltd. - Key news; Exhibits166: Sun Pharmaceutical Industries Ltd. - Key offerings; Exhibits167: Viatris Inc. - Overview; Exhibits168: Viatris Inc. - Business segments; Exhibits169: Viatris Inc. - Key news; Exhibits170: Viatris Inc. - Key offerings; Exhibits171: Viatris Inc. - Segment focus; Exhibits172: Inclusions checklist; Exhibits173: Exclusions checklist; Exhibits174: Currency conversion rates for US$; Exhibits175: Research methodology; Exhibits176: Information sources; Exhibits177: Data validation; Exhibits178: Validation techniques employed for market sizing; Exhibits179: Data synthesis; Exhibits180: 360 degree market analysis; Exhibits181: List of abbreviations

Pricing

Currency Rates

Single User Online Download $2,500
Global Site License Online Download $4,000

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now